Correction to: An update on the CNS manifestations of neurofibromatosis type 2

被引：0
|
作者：
Shannon Coy
Rumana Rashid
Anat Stemmer-Rachamimov
Sandro Santagata
机构：
[1] Brigham and Women’s Hospital,Division of Neuropathology, Department of Pathology
[2] Hale Building for Transformative Medicine,Department of Pathology
[3] BTM8002P,Department of Pathology
[4] Boston Children’s Hospital,undefined
[5] Harvard Medical School,undefined
[6] Laboratory for Systems Pharmacology,undefined
[7] Harvard Program in Therapeutic Science,undefined
[8] Massachusetts General Hospital,undefined
[9] Ludwig Center at Harvard,undefined
来源：
Acta Neuropathologica | 2020年 / 139卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
The article An update on the CNS manifestations of neurofibromatosis type 2, written by Shannon Coy, Rumana Rashid, Anat Stemmer‑Rachamimov and Sandro Santagata, was originally published electronically on the publisher’s internet portal (currently SpringerLink) on 04 June 2019 without open access.
引用
收藏
页码：667 / 667
相关论文
共 50 条
  • [31] Imaging Manifestations of Orbital Neurofibromatosis Type 1
    Milburn, James M.
    Gimenez, Carlos R., Jr.
    Dutweiler, Elizabeth
    OCHSNER JOURNAL, 2016, 16 (04): : 431 - 434
  • [32] Gastrointestinal and Retroperitoneal Manifestations of Type 1 Neurofibromatosis
    Ursula Basile
    Giuseppe Cavallaro
    Andrea Polistena
    Sandra Giustini
    Gennaro Orlando
    Dario Cotesta
    Luigi Petramala
    Claudio Letizia
    Stefano Calvieri
    Giorgio De Toma
    Journal of Gastrointestinal Surgery, 2010, 14 : 186 - 194
  • [33] Renal manifestations in children with neurofibromatosis type 1
    Celik, Binnaz
    Aksoy, Ozlem Yuksel
    Bastug, Funda
    Poyrazoglu, Hatice Gamze
    EUROPEAN JOURNAL OF PEDIATRICS, 2021, 180 (12) : 3477 - 3482
  • [34] Abdominal neoplastic manifestations of neurofibromatosis type 1
    Dare, Anna J.
    Gupta, Abha A.
    Thipphavong, Seng
    Miettinen, Markku
    Gladdy, Rebecca A.
    NEURO-ONCOLOGY ADVANCES, 2020, 2 : i124 - i133
  • [35] AAV-Mediated Phenotypic Correction of the CNS Manifestations of a Mouse Model of Mucopolysaccharidosis Type I
    Van de Graaf, Benjamin G.
    Wang, Marlene
    Kwaa, Abena
    Hackett, Neil R.
    Crystal, Ronald G.
    Sondhi, Dolan
    MOLECULAR THERAPY, 2014, 22 : S146 - S147
  • [36] NEUROCUTANEOUS MANIFESTATIONS OF NEUROFIBROMATOSIS-2
    SORIA, ED
    FINE, EJ
    CANDARAS, MM
    NEW YORK STATE JOURNAL OF MEDICINE, 1990, 90 (10) : 513 - 516
  • [37] Neurological manifestations of neurofibromatosis type 1: our experience
    Marco, S. B. Sanchez
    Pison, J. Lopez
    Escribano, C. Calvo
    Viejo, I. Gonzalez
    Gallart, M. D. Miramar
    Villagrasa, P. Samper
    NEUROLOGIA, 2022, 37 (05): : 325 - 333
  • [38] Dermatologic Manifestations of Neurofibromatosis Type 1 and Emerging Treatments
    Poplausky, Dina
    Young, Jade N. N.
    Tai, Hansen
    Rivera-Oyola, Ryan
    Gulati, Nicholas
    Brown, Rebecca M. M.
    CANCERS, 2023, 15 (10)
  • [39] Orthopaedic manifestations of neurofibromatosis type 1: A case report
    Nastase, Florentina
    Radaschin, Diana Sabina
    Niculet, Elena
    Bradeanu, Andrei Vlad
    Verenca, Madalina Codruta
    Nechita, Aurel
    Chioncel, Valentin
    Nwabudike, Lawrence Chukwudi
    Baroiu, Liliana
    Polea, Eduard Drima
    Fotea, Silvia
    Anghel, Lucretia
    Nechifor, Alexandru
    Tatu, Alin Laurentiu
    EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2022, 23 (02)
  • [40] Neurofibromatosis type 1 - Spinal manifestations of a systemic disease
    Restrepo, CS
    Riascos, RF
    Hatta, AA
    Rojas, R
    JOURNAL OF COMPUTER ASSISTED TOMOGRAPHY, 2005, 29 (04) : 532 - 539
12345